RT Journal Article
SR Electronic
T1 Microbiome-based biomarkers to guide personalized microbiome-based therapies for Parkinson’s disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.03.24305273
DO 10.1101/2024.04.03.24305273
A1 Payami, Haydeh
A1 Sampson, Timothy R
A1 Murchison, Charles F
YR 2024
UL http://medrxiv.org/content/early/2024/04/04/2024.04.03.24305273.abstract
AB We address an unmet challenge in Parkinson’s disease: the lack of biomarkers to identify the right patients for the right therapy, which is a main reason clinical trials for disease modifying treatments have all failed. We present the gut microbiome as a target for treatment and introduce microbiome-based biomarkers to guide personalized treatments. We show that not all persons with PD have a dysbiotic microbiome, and not all dysbiotic PD microbiomes have the same features. We have developed an intuitive and easily modifiable method to identify the optimal candidates for microbiome-based clinical trials, and subsequently, for treatments that are personalized for each individual’s dysbiotic features. We demonstrate the method for PD. The concept, and the method, is generalizable for any disease with a microbiome component.Competing Interest StatementHP has intellectual property pending on Personalized Microbiome-Based Therapies, Serial No.: 63/571,787; Filing Date: March 29, 2024. TRS is a co-inventor on intellectual property related to a small molecule microbiome-based therapy - US Patent 11,707,493 and 11,147, 792.Funding StatementThis work was supported by The Strain Endowed Chair in Parkinson's Disease to the University of Alabama at Birmingham (HP) and Aligning Science Across Parkinson's (ASAP-020527) through the Michael J. Fox Foundation for Parkinson's Research (MJFF) (HP, TRS, CFM). For the purpose of open access, the authors have applied a CC BY public copyright license to all Author Accepted Manuscripts arising from this submission. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the funding agencies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used ONLY openly available human data that were originally published in Nat Comm (https://www.nature.com/articles/s41467-022-34667-x). The raw metagenomic sequences and accompanying metadata are located at the NCBI SRA under BioProject ID PRJNA834801 (https://www.ncbi.nlm.nih.gov/bioproject/834801), and post-QC and post taxonomic profiling data are on Zenodo (https://zenodo.org/record/7246185).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe datasets used for biomarker development are openly public with no restrictions [https://www.nature.com/articles/s41467-022-34667-x]. The raw metagenomic sequences and accompanying metadata are at the NCBI SRA under BioProject ID PRJNA834801 [https://www.ncbi.nlm.nih.gov/bioproject/834801], and post-QC and post taxonomic profiling data are on Zenodo [https://zenodo.org/record/7246185].